COVID-19 in Patients with Multiple Sclerosis: Associations with Disease-Modifying Therapies

Background Disease-modifying therapies (DMTs) for multiple sclerosis (MS) target immunity and have the potential to increase the risk of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection and alter its clinical course. We assessed these risks in patients with MS (PwMS). Objective...

Full description

Saved in:

Bibliographic Details
Published in:	CNS drugs Vol. 35; no. 3; pp. 317 - 330
Main Authors:	Reder, Anthony T., Centonze, Diego, Naylor, Maria L., Nagpal, Anjali, Rajbhandari, Rajani, Altincatal, Arman, Kim, Michelle, Berdofe, Aaron, Radhakrishnan, Maha, Jung, Eunice, Sandrock, Alfred W., Smirnakis, Karen, Popescu, Catrinel, de Moor, Carl
Format:	Journal Article
Language:	English
Published:	Cham Springer International Publishing 01.03.2021 Springer Nature B.V
Subjects:	Adolescent Adult Aged Aged, 80 and over Alemtuzumab - therapeutic use Autoimmune diseases Azathioprine - therapeutic use Black or African American - statistics & numerical data Body mass index CD20 antigen Cladribine - therapeutic use Comorbidity Copolymer 1 Coronaviridae Coronaviruses COVID-19 COVID-19 - epidemiology COVID-19 - mortality Crotonates - therapeutic use Cyclophosphamide - therapeutic use Cyclosporine - therapeutic use Databases, Factual Dimethyl Fumarate - therapeutic use Disease Electronic medical records Ethnicity Female Fingolimod Hydrochloride - therapeutic use Hospitalization - statistics & numerical data Humans Hydroxybutyrates Immunologic Factors - therapeutic use Immunosuppressive Agents - therapeutic use Incidence Infections Interferon Interferon-beta - therapeutic use Logistic Models Lupus Lupus Erythematosus, Systemic - drug therapy Lupus Erythematosus, Systemic - epidemiology Male Medicine Medicine & Public Health Methotrexate - therapeutic use Middle Aged Mitoxantrone - therapeutic use Monoclonal antibodies Morbidity Multiple sclerosis Multiple Sclerosis - drug therapy Multiple Sclerosis - epidemiology Mycophenolic Acid - therapeutic use Natalizumab - therapeutic use Neurology Neurosciences Nitriles Obesity - epidemiology Original Original Research Article Pandemics Pharmacotherapy Polymerase chain reaction Population Psychiatry Psychopharmacology Risk Factors Rituximab - therapeutic use Safety SARS-CoV-2 Severe acute respiratory syndrome coronavirus 2 Systemic lupus erythematosus Toluidines - therapeutic use United States - epidemiology White People - statistics & numerical data Young Adult United States United States > US
ISSN:	1172-7047, 1179-1934, 1179-1934
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!